Calcineurin Inhibitor Dosing Requirements in HIV Positive Kidney Transplant Recipients.

被引：0
|
作者：
Sievers, Theodore M. [1 ]
Emami, Sina [1 ]
Wilkinson, Alan [1 ]
Danovitch, Gabriel [1 ]
Pham, Phuong-Thu [1 ]
Bunnapradist, Suphamai [1 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2010年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：398 / 398
页数：1
相关论文
共 50 条
  • [1] Unexpected Early Calcineurin Inhibitor Nephrotoxicity in Pediatric Kidney Transplant Recipients.
    Yanik, M.
    Mannon, R.
    Seifert, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 750 - 750
  • [2] Belatacept Conversion for Calcineurin Inhibitor-Associated Thrombotic Microangiopathy in Kidney Transplant Recipients.
    Muhsin, S. A.
    Safa, K.
    Gilligan, H. M.
    Heher, E. C.
    Williams, W. W.
    Wojciechowski, D. M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 691 - 691
  • [3] Genomic-Derived Markers to Identify Calcineurin Inhibitor Nephrotoxicity in Pediatric Kidney Transplant Recipients.
    Rhone, E.
    Gehrau, R.
    Bontha, S.
    Walker, P.
    Dumur, C.
    Maluf, D.
    Mas, V.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 742 - 742
  • [4] Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients
    Karpe, Krishna M.
    Talaulikar, Girish S.
    Walters, Giles D.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (07):
  • [5] Experience With Everolimus Following Calcineurin Inhibitor Withdrawal in Liver Transplant Recipients.
    Fischer, L.
    Fung, J.
    Metselaar, H.
    Kaiser, G.
    Schemmer, P.
    Neuhaus, P.
    Dong, G.
    Junge, G.
    Schlitt, H.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 714 - 715
  • [6] Experience With Everolimus Following Calcineurin Inhibitor Withdrawal in Liver Transplant Recipients.
    Fischer, L.
    Fung, J.
    Metselaar, H.
    Kaiser, G.
    Schemmer, P.
    Neuhaus, P.
    Dong, G.
    Junge, G.
    Schlitt, H.
    [J]. TRANSPLANTATION, 2014, 98 : 714 - 715
  • [7] Short-Term Outcomes of the Calcineurin Inhibitor Avoidance Maintenance Regimen with Everolimus in Kidney Transplant Recipients.
    Kutsunai, K.
    Iwadoh, K.
    Horibe, T.
    Ogawa, Y.
    Kai, K.
    Murakami, T.
    Koyama, I.
    Nakajima, I.
    Fuchinoue, S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 316 - 316
  • [8] BK nephropathy in HIV positive renal transplant recipients.
    Blumberg, Emily
    Barin, Burc
    Bloom, Roy
    Roland, Michelle
    Olson, Jean
    Wali, Ravinder
    Guasch, Antonio
    Zhang, Rubin
    Pavlakis, Martha
    Stock, Peter
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 460 - 460
  • [9] Calcineurin Inhibitors, Macrolides, and the Risk of Adverse Drug Events in Kidney Transplant Recipients.
    Jeong, R.
    Quinn, R.
    Ravani, P.
    Lentine, K.
    Lloyd, A.
    Hemmelgarn, B.
    Wen, K.
    Braam, B.
    Gourishankar, S.
    Wong, A.
    Lam, N.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 807 - 807
  • [10] Proton Pump Inhibitor Use among Kidney Transplant Recipients.
    Wilson, N.
    Bala, S.
    Concepcion, B.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 928 - 928
12345